Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | Open-market sale · 10b5-1 plan | SELL | $86K 2,393 sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $251K 2,320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.80M 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 18 | Atay OguzhanDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $434K 4,009 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsuchimoto Kim RDirector | Open-market sale · 10b5-1 plan | SELL | $43K 600 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 18 | O Connor Kevin JDirector | Open-market sale · 10b5-1 plan | SELL | $6,713 110 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 18 | Syrvalin Kristine CEVP General Counsel | Open-market sale · 10b5-1 plan | SELL | $102K 4,643 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Jordan Joseph HughDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.54M 4,870 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Felice Laura L.EVP, Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1.11M 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $353K 3,241 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | van Houte HansChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $51K 3,300 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Stat Lauren Elaina FriedmanDirector | Open-market sale · 10b5-1 plan | SELL | $253K 1,358 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Anderson RaymondDirector | Open-market sale · 10b5-1 plan | SELL | $56K 840 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $8.81M 174.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Hendry Gregory LChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $19K 2,443 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Palmer Benjamin EdwardSVP, Pres Commercial | Open-market sale · 10b5-1 plan | SELL | $154K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Kleinerman ChristianEVP, Product Management | Open-market sale · 10b5-1 plan | SELL | $3.06M 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $6.71M 133.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.34M 29.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Tsuchimoto Kim RDirector | Open-market sale · 10b5-1 plan | SELL | $92K 1,295 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Puri Michal NathChief Human Resources Officer | Open-market sale | SELL | $8,738 660 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Wassenaar YvonneDirector | Open-market sale · 10b5-1 plan | SELL | $84K 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $150K 2,738 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Vassil JonathanChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $145K 2,363 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $185K 3,094 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $63K 1,129 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Bhutani Amanpal SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $530K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Daspit MarisaCHIEF PEOPLE OFFICER | Open-market sale · 10b5-1 plan | SELL | $36K 720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $81K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $184K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $212K 3,283 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Nonko EugeneDirector | Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |